2016 M&A Review - China pharmaceutical and medical device

Apr 2017

M&A in China’s medical device sector hit record high in 2016, with deal volumes up by 40% and values up by 12% at US$7.68 billion. While in pharmaceutical sector it increased slightly in 2016 in terms of deal volume, with deal value down by 34% at US$20.58 billion. 

Contact us

Mark Gilbraith

China & Hong Kong Management Consulting Leader, Health Industries Leader and Consumer & TMT Consulting Leader, PwC China

Tel: +[86] (21) 2323 2898

Xun Tang

China Central Transaction Services Leader, PwC Hong Kong

Tel: +[86] (21) 2323 3396

Follow us